New York Approves Cannabis for Anxiety: Clinical Evidence Review
Cannabis for anxiety disorders is a growing topic in medical cannabis policy. Current clinical evidence remains mixed, with some studies showing limited benefits. Patients and clinicians should carefully consider the risks and monitor outcomes.
Three Kids Hospitalized After THC Gummies at Eagles Landing Middle School
Pediatric THC gummy ingestion is an increasing concern in emergency settings. This incident at Eagles Landing Middle School highlights the risks of accidental cannabis exposure in children. Clinicians must recognize symptoms and counsel families on safe…
Honoring the Trailblazers with MS Who Changed Cannabis Policy
Multiple sclerosis cannabis advocacy has played a pivotal role in shaping medical cannabis policy. MS patients were among the first to demonstrate therapeutic benefits of cannabinoids in clinical settings. Their efforts helped establish evidence-based…
Schaumburg Family Advocates for Medical Cannabis Policy Improvements
Medical cannabis policy evolution is driven by ongoing patient advocacy efforts. The Schaumburg family continues to push for improvements in state and federal laws. These changes directly impact clinical access and treatment options for patients.
CED Regulatory Digest: Latest Cannabinoid Labeling Guidance Updates
This CED Regulatory Digest covers the latest cannabinoid labeling guidance updates from the FDA docket. It highlights key compliance posture changes and agency comment reviews. Stay informed on regulatory developments affecting cannabinoid products.
Policy Watch: 5 Regulatory Updates — March 19, 2026
This update covers DEA scheduling synthetic opioids 2026 regulatory actions affecting controlled substances. These changes influence clinical practices involving controlled drugs. Cannabis medicine remains primarily governed by state laws and federal…
Policy Watch: 17 Regulatory Updates — March 14, 2026
This update covers federal cannabis regulatory updates relevant to clinicians and patients. Key DEA scheduling actions affect synthetic cannabinoids and controlled substances. Understanding these federal cannabis regulatory updates is essential for…
Alabama Medical Cannabis Program Now Accepting Patient Registrations
Alabama medical cannabis patient registration is now open for qualifying patients. This program offers legal access to cannabis for conditions like chronic pain and PTSD. Patients must register and obtain physician certification to participate.
From Seed to Success: Shawn Collins and the Massachusetts Cannabis Industry
The Massachusetts cannabis industry has grown significantly under Shawn Collins' leadership. His regulatory efforts have ensured safe access to medical cannabis. This growth benefits patients and consumers alike.